|Mrs. Lusia Halina Guthrie||Co-Founder and Corp. Advisor||371k||N/A||N/A|
|Mr. Daniel L. Hill B.A (Acc),CA, MBA, MAppFin, FFin, CSA||Chief Financial Officer and Company Sec.||73k||N/A||N/A|
|Mr. Peter M. Bradley||VP of Global Bus. Devel.||220k||N/A||N/A|
|Mr. Brenton Barnes||Chief Exec. Officer, Managing Director and Director||N/A||N/A||N/A|
|Dr. Steven Giglio||Scientific Director||N/A||N/A||N/A|
LBT Innovations Limited researches and develops clinical and diagnostic technologies for the healthcare and laboratory supply markets in Australia, Switzerland, and the United States. It offers PREVI Isola, an automated streaking and inoculation system; and automated plate assessment system, a platform technology for the automation of culture-plate screening and interpretation. The company was founded in 2004 and is based in Adelaide, Australia.
LBT Innovations Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.